“…While effective prevention programs and antiviral therapies for hepatitis B and C will lower the incidence of HCC, emerging socioeconomic issues will deliver new at-risk populations. …”

“…The first part reviews the treatment of hepatitis C virus infection, the management of virus-related acute retinal necrosis, the use of leflunomide therapy in renal transplant patients, and mathematical modeling of HIV-1 treatment responses. …”

Tabla de Contenidos: “…Infecciones por el virus del papiloma humano; 22. Hepatitis virales; 23. Virus de la infl uenza; 24. …”

Tabla de Contenidos: “…Genetic Disease -- Down Syndrome Part 1 -- Down Syndrome Part 2 -- Fragile X-Associated Mental Retardation -- Leber Hereditary Optic Neuropathy -- Osteogenesis -- Imperfecta -- Phenylketonuria -- Disorders of the Immune System -- Acquired Immunodeficiency Syndrome (AIDS) -- Allergic Rhinitis -- Chronic Granulomatous Disease -- Common Variable Immunodeficiency -- Severe Combined Immunodeficiency Disease -- X-Linked Agammaglobulinemia -- Infectious Diseases -- Diarrhea, -- Infectious -- Infective Endocarditis -- Meningitis -- Pneumonia -- Sepsis, Sepsis Syndrome, Septic Shock -- Neoplasia -- Breast Cancer -- Carcinoid Syndrome from -- Neuroendocrine Tumer (NET) -- Colon Carcinoma -- Leukemia -- Lymphoma -- Osteosarcomas -- Paraneoplastic Syndrome -- Testicular Carcinoma -- Blood Disorders -- Cyclic Neutropenia -- Hypercoagulable States -- Immune Thrombocytopenic Purpura -- Iron Deficiency Anemia -- Vitamin B12 Deficiency/Pernicious Anemia -- Nervous System Disorders -- Amyotrophic Lateral Sclerosis (Motor Neuron Disease) -- Cerebellar Ataxia -- Dementia: Alzheimer Disease -- Myasthenia Gravis -- Parkinson Disease -- Seizure -- Stroke -- Diseases of the Skin -- Acne -- Bullous Pemphigoid -- Erythema Multiforme -- Erythema Nodosum -- Leukocytoclastic -- Vasculitis -- Lichen Planus -- Poison Ivy/Oak -- Psoriasis -- Sarcoidosis -- Urticaria -- Pulmonary Disease -- Acute Respiratory Distress Syndrome (ARDS) -- Asthma -- Chronic Obstructive Pulmonary Disease (COPD) -- Interstitial Pulmonary Fibrosis -- Pulmonary Edema -- Pulmonary Embolism -- Cardiovascular Disorders: Heart Disease -- Aortic Regurgitation -- Aortic Stenosis -- Coronary Artery Disease -- Heart Failure -- Mitral Regurgitation -- Mitral Stenosis -- Pericarditis -- Pericaridal Effusion with Tamoponade -- Tachycardias -- Cardiovascular Disorders: Vascular Disease -- Atherosclerosis -- Hypertension -- Shock -- Disorders of the Adrenal Medulla -- Pheochromocytoma -- Gastrointestinal Disease -- Achalasia -- Cholelithiasis and Cholecystitis -- Crohn Disease -- Diarrhea, -- Non-Infectious: Lactose Intolerance -- Diverticulitis -- Gastroparesis -- Irritable Bowel Syndrome -- Peptic Ulcer Disease -- Reflux Esophagitis -- Ulcerative Colitis -- Liver Disease -- Acute Hepatitis -- Chronic Hepatitis B -- Cirrhosis -- Disorders of the Exocrine Pancreas -- Acute Pancreatitis -- Carcinoma of the Pancreas -- Chronic Pancreatitis -- Pancreatic Insufficiency -- Renal Disease -- Acute Kidney Injury: Acute Tubular Necrosis -- Chronic Kidney Disease -- Nephrotic Syndrome: Minimal Change Disease -- Poststreptococcal Glomerulonephritis -- Renal Stone Disease -- Disorders of the Parathyroids & Calcium & Phosphorus Metabolism -- Familial Hypocalciuric Hypercalcemia -- Hypercalcemia of Malignancy -- Hypoparathyroidism and Pseudohypoparathyroidism -- Medullary Carcinoma of the Thyroid -- Osteomalacia -- Osteoporosis -- Primary Hyperparathyroidism -- Disorders of the Endocrine Pancreas -- Diabetes Mellitus: Diabetic Ketoacidosis -- Glucagonoma -- Hypoglycemia -- Somatostatinoma -- Type 1 Diabetes Mellitus -- Disorders of the Hypothalamus & Pituitary Gland -- Diabetes Insipidus -- Hypopituitarism -- Obesity -- Pituitary Adenoma -- Syndrome of Inapprorpiate ADH (SIADH) -- Thyroid Disease -- Familial Euthyroid Hyperthyroxinemia -- Goiter -- Hyperthyroidism -- Hypothyroidism -- Subclinical Hyperthyroidism -- Subclinical Hypothyroidism -- Thyroid Nodule and Neoplasm -- Disorders of the Adrenal Cortex -- Addison Disease -- Adrenal "Incidentaloma" -- Congenital Adrenal Hyperplasia -- Cushing Syndrome -- Hyperaldosteronism (Primary Aldosteronism) -- Type 4 Hyporeninemic Hypoaldosteronism -- Disorders of the Female Reproductive Tract -- Endometrial Carcinoma -- Female Infertility -- Menstrual Disorders: Dysmenorrhea -- Polycystic Ovarian Syndrome (PCOS) -- Preeclampsia-Eclampsia -- Disorders of the Male Reproductive Tract -- Benign Prostatic Hyperplasia -- Male Infertility -- Inflammatory Rheumatic Diseases� -- Ankylosing Spondylitis -- Gout -- Immune Complex Vasculitis -- Polymyositis -- Rheumatoid Arthritis -- Sjögren -- Syndrome -- Systemic Lupus Erythematosus…”

Tabla de Contenidos: “…-- Conozca su condición -- Conozca sus opciones -- Tome una decisión -- Fuente -- Tratamiento de la hepatitis C crónica: Revisión de la investigación para adultos -- John M. …”

Tabla de Contenidos: “…CHIMPANZEES IN RESEARCH -- Copyright -- PREFACE -- Contents -- CHIMPANZEES IN RESEARCH STRATEGIES FOR THEIR ETHICAL CARE, MANAGEMENT, AND USE -- EXECUTIVE SUMMARY -- 1 INTRODUCTION -- 2 RESEARCH NEEDS -- VALUE OF PAST STUDIES WITH CHIMPANZEES -- INFECTIOUS DISEASE -- XENOBIOTICS -- FUTURE NEEDS FOR CHIMPANZEES -- KNOWN INFECTIOUS AGENTS -- HEPATITIS -- RSV -- HIV -- MALARIA -- EMERGING INFECTIOUS AGENTS -- OTHER RESEARCH -- MAXIMIZING THE AVAILABILITY OF CHIMPANZEES -- TERMINAL STUDIES -- CONCLUSIONS AND RECOMMENDATIONS -- 3 LONG-TERM CARE -- HOUSING STANDARDS AND BEHAVIORAL WELL-BEING -- HOUSING MODELS -- PROVISIONS FOR BEHAVIORAL WELL-BEING -- SPECIAL CONSIDERATIONS -- EUTHANASIA -- RECOMMENDATIONS FOR THE PRACTICE OF EUTHANASIA ENDORSED BY THE COMMITTEE -- CHIMPANZEE POPULATION SUBGROUPS: DEFINITIONS AND RECOMMENDATIONS -- GROUP A: BREEDING POPULATION -- GROUP B: AVAILABLE FOR RESEARCH -- GROUP C: CURRENTLY IN RESEARCH PROTOCOLS -- GROUP D: NOT NEEDED FOR RESEARCH OR BREEDING -- OWNERSHIP TRANSFER -- CONCLUSIONS -- 4 DEMOGRAPHY, COST, AND GENETIC MATERIAL -- DEMOGRAPHY -- MODELS OF BREEDING COLONY SIZE -- COSTS -- PROJECTED BREEDING COLONY COSTS -- REDUCING COSTS THROUGH SIMPLIFYING FUNDING AND ENHANCING COORDINATION -- SANCTUARY CONSTRUCTION -- GENETIC MANAGEMENT -- FUTURE BREEDING -- CRYOPRESERVATION OF GAMETES OR EMBRYOS -- RECOMMENDATIONS -- 5 CENTRALIZATION OF RESEARCH CHIMPANZEE MANAGEMENT AND DEVELOPMENT OF A NATIONAL CHIMPANZEE RESOURCE -- OWNERSHIP -- FINANCIAL SUPPORT OF THE NATIONAL CHIMPANZEE RESOURCE (NCR) -- PRIVATELY OWNED CHIMPANZEES IN BIOMEDICAL RESEARCH -- CHIMPANZEE SANCTUARIES -- THE NATIONAL CHIMPANZEE MANAGEMENT PROGRAM ADVISORY COUNCIL -- CHARGE -- DUTIES -- MEMBERSHIP -- REFERENCES -- APPENDIX A MINORITY STATEMENT -- REFERENCES…”

Tabla de Contenidos: “…. -- Agent: Rickettsia rickettsii -- Viral Agents -- Agent: Hepatitis A virus -- Agent: Hepatitis B, hepatitis non-A non-B -- Agent: Herpesvirus simiae (B-virus) -- Agent: Herpesviruses -- Agent: Influenza virus -- Agent: Lymphocytic choriomeningitis (LCM) virus -- Agent: Poliovirus -- Agent: Poxviruses -- Agent: Rabies virus -- Agents: Transmissible spongiform encephalopathies (Creutzfeldt-Jakob and kuru agents) -- Agent: Vesicular stomatitis virus (VSV) -- ARBOVIRUSES -- Arboviruses Assigned to Biosafety Level 2 -- Arboviruses and Arenaviruses Assigned to Biosafety Level 3 -- Arboviruses, Arenaviruses, or Filoviruses Assigned to Biosafety Level 4 -- APPENDIX A BIOLOGICAL SAFETY CABINETS -- APPENDIX A IMMUNOPROPHYLAXIS -- APPENDIX A SURVEILLANCE OF PERSONNEL FOR LABORATORY-ASSOCIATED RICKETTSIAL INFECTIONS -- APPENDIX A IMPORTATION AND INTERSTATE SHIPMENT OF HUMAN PATHOGENS AND RELATED MATERIALS -- APPENDIX A RESTRICTED ANIMAL PATHOGENS -- APPENDIX A.6 RESOURCES FOR INFORMATION -- LITERATURE CITED -- Appendix B 1988 Agent Summary Statement for HIVs, Including HTLV-III, LAV, HIV-1, and HIV-2 -- CONTENTS -- 1988 AGENT SUMMARY STATEMENT FOR HIVS, INCLUDING HTLV-III, LAV, HIV-1, AND HIV-2 -- INTRODUCTION -- HIV AGENT SUMMARY STATEMENT AGENT: HIVS INCLUDING HTLV-III, LAV, HIV-1, AND HIV-2 -- LABORATORY HAZARDS -- RECOMMENDED PRECAUTIONS -- ADDENDUM 1 -- LABORATORY BIOSAFETY LEVEL CRITERIA -- Biosafety Level 2 -- Biosafety Level 3 -- VERTEBRATE ANIMAL BIOSAFETY LEVEL CRITERIA -- Animal Biosafety Level 2 -- Animal Biosafety Level 3 -- ADDENDUM 2- CDC CAUTIONARY NOTICE -- REFERENCES…”

Tabla de Contenidos: “…Nursing practice and the nursing process -- Standards of care, ethical and legal issues -- Health promotion and preventive care -- Genetics and health applications -- Adult physical assessment -- I.V. therapy -- Perioperative nursing -- Cancer nursing -- Care of the older or disabled adult -- Respiratory function and therapy -- Respiratory disorders -- Cardiovascular function and therapy -- Cardiac disorders -- Vascular disorders -- Neurologic disorders -- Eye disorders -- Ear, nose, and throat disorders -- Gastrointestinal disorders -- Hepatic, biliary, and pancreatic disorders -- Nutritional problems -- Renal and urinary disorders -- Gynecologic disorders -- Breast conditions -- Endocrine disorders -- Diabetes mellitus -- Hematologic disorders -- Transfusion therapy and blood and marrow stem cell transplantation -- Asthma and allergy -- HIV disease and AIDS -- Connective tissue disorders -- Infectious diseases -- Musculoskeletal disorders -- Dermatologic disorders -- Burns -- Emergent conditions -- Maternal and fetal health -- Nursing management during labor and delivery -- Care of mother and neonate during the postpartum period -- Complications of the childbearing experience -- Pediatric growth and development -- Pediatric physical assessment -- Pediatric primary care -- Care of the sick or hospitalized child -- Pediatric respiratory disorders -- Pediatric cardiovascular disorders -- Pediatric neurologic disorders -- Pediatric eye and ear problems -- Pediatric gastrointestinal and nutritional disorders -- Pediatric renal and genitourinary disorders -- Pediatric metabolic and endocrine disorders -- Pediatric oncology -- Pediatric hematologic disorders -- Pediatric immunologic disorders -- Pediatric orthopedic problems -- Pediatric integumentary disorders -- Developmental disabilities -- Problems of mental health…”
Enlace del recurso

Tabla de Contenidos: “…La escuela 68; CAPÍTULO 3; El suceso de la hepatitis; 1. El inicio; 2. La crisis; 3. Desenlace y vuelta a la normalidad; 4. …”

Tabla de Contenidos: “…'A vaccine for the nation': South Korea's development of a hepatitis B vaccine and national prevention strategy focused on newborns / Eun Kyung Choi and Young-Gyung Paik --Part II: Nationality, vaccine production, and the end of sovereign manufacture --5. …”

“…GP is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infection with or without compensated cirrhosis (Table 2). …”

Tabla de Contenidos: “…BLOOD AND BLOOD PRODUCT REGULATION -- Statutory Background -- Biologics Act -- Public Health Service Act -- Blood Shield Laws -- Federal Licensure of Blood Collection Organizations -- Establishment Licensure and Registration -- Product Licensure -- Other Required Licensure -- REGULATORY AUTHORITY OF THE FDA -- Compliance with Regulations -- Recall Policy -- SUMMARY -- REFERENCES -- 3 History of the Controversy -- INTRODUCTION -- THE RISK OF AIDS -- Kaposi's Sarcoma and PCP in Homosexual Men -- Opportunistic Infections Among Heterosexual Intravenous (IV) Drug Users and Haitian Immigrants -- Increased Risk Among Individuals with Hemophilia and a Similarity to Hepatitis B -- Further Evidence of Sexual and Blood-Borne Transmission of AIDS -- Summary -- IMMEDIATE RESPONSES TO EVIDENCE OF BLOOD-BORNE AIDS TRANSMISSION -- The CDC's Public Meeting -- The Blood Bank Community's Statement -- Position of the National Hemophilia Foundation -- Position of the Plasma Fractionation Industry -- Federal Recommendations on the Prevention of AIDS -- Summary and Comment -- RECONSIDERING THE EVIDENCE: FURTHER ATTEMPTS TO FORMULATE POLICIES -- Summary and Comment -- RESEARCH ACTIVITIES -- The Public Health Service Effort -- Isolation of the Virus and Development of a Screening Test -- Summary and Comment -- REFERENCES -- 4 Product Treatment -- INTRODUCTION -- CRITICAL TIME PERIOD: 1970-1983 -- Hepatitis -- Viral Inactivation of AHF Concentrate -- Early Methods -- Studies by U.S. …”

Tabla de Contenidos: “…About the Editor -- Preface to "Ecology and Conservation of Freshwater Fishes Biodiversity" -- Ecology and Conservation of Freshwater Fishes Biodiversity: We Need More Knowledge to Develop Conservation Strategies -- Fish Ecology of the Alto Madre de Dios River Basin (Peru): Notes on Electrofishing Surveys, Elevation, Palm Swamp and Headwater Fishes -- Variability in Population Traits of a Sentinel Iberian Fish in a Highly Modified Mediterranean-Type River -- Scientific Methods to Understand Fish Population Dynamics and Support Sustainable Fisheries Management -- Plasticity in Reproductive Traits, Condition and Energy Allocation of the Non-Native Pyrenean Gudgeon Gobio lozanoi in a Highly Regulated Mediterranean River Basin -- Fish Rescue during Streamflow Intermittency May Not Be Effective for Conservation of Rio Grande Silvery Minnow -- Factors Influencing Abundances and Population Size Structure of the Threatened and Endemic Cyprinodont Aphanius iberus in Mediterranean Brackish Ponds -- Fish Biodiversity Conservation and Restoration, Yangtze River Basin, China, Urgently Needs 'Scientific' and 'Ecological' Action -- First Captive Breeding Program for the Endangered Pyrenean Sculpin (Cottus hispaniolensis Bacescu-Master, 1964) -- Interpopulation Variability in Dietary Traits of Invasive Bleak Alburnus alburnus(Actinopterygii, Cyprinidae) Across the Iberian Peninsula -- Assessing the Fish Stock Status in Lake Trichonis: A Hydroacoustic Approach -- Changes in the Fish Community of a Western Caribbean Estuary after the Expansion of an Artificial Channel to the Sea -- Hepatic Steatosis in a Bullhead (Cottus gobio) Population from a High-Mountain Lake (Carnic Alps): Adaptation to an Extreme Ecosystem? …”

“…Examining the effects of punitive drug policy, inadequate social services, and looming public health risks, including HIV/AIDS and hepatitis C, the book gives voice to women silenced by shame. …”

“…They explore the important intersections of drug ethnography with globalization, criminalization, public health (including the HIV/AIDS epidemic, hepatitis, and other diseases), and gender, and also provide a practical guide of the methods and career paths of ethnographers…”

Tabla de Contenidos: “….); INTRODUCCIÓN; EL MERCADO DEL CEBOLLÍN MEXICANO (...); EL BROTE DE HEPATITIS ""A""; EL IMPACTO ECONÓMICO DEL BROTE; RESPUESTA ORGANIZADA AL BROTE; CONCLUSIONES; BIBLIOGRAFÍA; ECONOMÍA, POBLACIÓN Y EFICIENCIA (...); INTRODUCCIÓN; DINAMISMO DE LA ECONOMÍA (...); DINAMISMO DE LA POBLACIÓN (...); DEMANDA Y OFERTA FUTURA DE AGUA (...); LAS OPCIONES DE LAS NUEVAS FUENTES (...); EL ANÁLISIS DE SISTEMAS PARA LA DISTRIBUCIÓN (...); CONCLUSIONES; BIBLIOGRAFÍA…”

Tabla de Contenidos: “…Animal model studies on viral infections --Animal models for human Herpesvirus 6 infection --Animal models for Ebola and Marburg virus infections --Hepatitis C virus infection and related liver disease: the quest for the best animal model --Can non-human primates serve as models for investigating Dengue disease pathogenesis? …”

“…When sofosbuvir-based medicines launched in 2013, they promised a cure for millions of patients worldwide with hepatitis C. But their sticker shock-the drug was dubbed "the $1,000-a-day pill"-intensified a global debate over the pricing of new medicines. …”

“…There is detailed emphasis on harm minimization, AIDS and hepatitis C and entirely new coverage of tobacco addiction and its management. …”